COSMOS Pharmaceutical Corporation(JP:3349)
¥6,545.00-35.00 (-0.53%)
JP:3349
COSMOS Pharmaceutical Corporation financials statements
¥6,545.00
At close:-35.00 (-0.53%)
Want to see JP:3349 full AI Analyst Report?
COSMOS Pharmaceutical Corporation (3349) Income Statement
1 Followers
COSMOS Pharmaceutical Corporation Income Statement
Last quarter (Q1 2027), COSMOS Pharmaceutical Corporation's total revenue was ¥286.65B, an increase of 5.23% from the same quarter last year. In Q1, COSMOS Pharmaceutical Corporation's net income was ¥8.25B. See COSMOS Pharmaceutical Corporation’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | May 26 | May 25 | May 24 | May 23 | May 22 |
|---|---|---|---|---|---|
| ¥ 1.10T | ¥ 1.01T | ¥ 964.99B | ¥ 827.70B | ¥ 755.41B | |
| ¥ 229.68B | ¥ 213.28B | ¥ 188.31B | ¥ 168.72B | ¥ 151.45B | |
| ¥ 187.33B | ¥ 172.88B | ¥ 156.81B | ¥ 138.59B | ¥ 121.65B | |
| Depreciation and Amortization | ¥ 24.58B | ¥ 22.23B | ¥ 19.92B | ¥ 17.37B | ¥ 15.11B |
| ¥ 66.48B | ¥ 64.85B | ¥ 53.74B | ¥ 50.19B | ¥ 48.21B | |
| ¥ 42.35B | ¥ 40.40B | ¥ 31.50B | ¥ 30.13B | ¥ 29.80B | |
| ¥ 1.86B | ¥ 1.97B | ¥ 2.22B | ¥ 2.64B | ¥ 3.25B | |
| ¥ 44.22B | ¥ 42.37B | ¥ 33.72B | ¥ 32.77B | ¥ 33.05B | |
| ¥ 32.05B | ¥ 30.98B | ¥ 24.45B | ¥ 23.80B | ¥ 23.16B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 404.33 | ¥ 390.85 | ¥ 308.61 | ¥ 300.48 | ¥ 292.37 |
| Diluted EPS | ¥ 404.33 | ¥ 390.85 | ¥ 308.61 | ¥ 300.48 | ¥ 292.37 |
| Weighted Average Shares Outstanding | 79.26M | 79.26M | 79.24M | 79.20M | 79.20M |
| Weighted Average Shares Outstanding (Diluted) | 79.26M | 79.26M | 79.24M | 79.20M | 79.20M |
Currency in JPY

